HomeCompareMTP vs MCD

MTP vs MCD: Dividend Comparison 2026

MTP yields 701.51% · MCD yields 2.34%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MTP wins by $924938.12M in total portfolio value
10 years
MTP
MTP
● Live price
701.51%
Share price
$0.29
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$924938.20M
Annual income
$722,372,390,440.71
Full MTP calculator →
MCD
McDonald's Corporation
● Live price
2.34%
Share price
$310.79
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$25,833.37
Full MCD calculator →

Portfolio growth — MTP vs MCD

📍 MTP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMTPMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MTP + MCD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MTP pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MTP
Annual income on $10K today (after 15% tax)
$59,628.20/yr
After 10yr DRIP, annual income (after tax)
$614,016,531,874.60/yr
MCD
Annual income on $10K today (after 15% tax)
$198.56/yr
After 10yr DRIP, annual income (after tax)
$21,958.36/yr
At 15% tax rate, MTP beats the other by $614,016,509,916.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MTP + MCD for your $10,000?

MTP: 50%MCD: 50%
100% MCD50/50100% MTP
Portfolio after 10yr
$462469.14M
Annual income
$361,186,208,137.04/yr
Blended yield
78.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

MTP
No analyst data
Altman Z
-17.1
Piotroski
1/9
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+13.2% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MTP buys
0
MCD buys
0
No recent congressional trades found for MTP or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMTPMCD
Forward yield701.51%2.34%
Annual dividend / share$2.00$7.26
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3%
Portfolio after 10y$924938.20M$77.7K
Annual income after 10y$722,372,390,440.71$25,833.37
Total dividends collected$908543.22M$57.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: MTP vs MCD ($10,000, DRIP)

YearMTP PortfolioMTP Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$80,851$70,150.82$10,812$332.41+$70.0KMTP
2$616,581$530,070.28$11,819$488.02+$604.8KMTP
3$4,437,682$3,777,940.56$13,111$724.37+$4.42MMTP
4$30,160,247$25,411,927.64$14,832$1,091.05+$30.15MMTP
5$193,682,255$161,410,790.66$17,219$1,675.85+$193.67MMTP
6$1,175,972,185$968,732,172.36$20,688$2,641.85+$1175.95MMTP
7$6,755,308,275$5,497,018,037.06$25,990$4,309.70+$6755.28MMTP
8$36,739,695,007$29,511,515,151.87$34,590$7,351.77+$36739.66MMTP
9$189,313,837,689$150,002,364,032.24$49,535$13,285.25+$189313.79MMTP
10$924,938,196,768$722,372,390,440.71$77,746$25,833.37+$924938.12MMTP

MTP vs MCD: Complete Analysis 2026

MTPStock

Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Full MTP Calculator →

MCDConsumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this MTP vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MTP vs SCHDMTP vs JEPIMTP vs OMTP vs KOMTP vs MAINMTP vs YUMMTP vs QSRMTP vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.